Corporate Office Properties Trust (COPT) (NYSE: OFC) is an office REIT headquartered in Columbia, Maryland, which is equidistant between Baltimore and Washington, DC. As of December 31, 2016, COPT’s core portfolio of 152 office properties encompassed 16.3 million square feet and was 94.4% leased.

  • Positive outlook for defense spending in the United States supports expectations for increased demand for COPT’s unique locations and, by extension, attractive cash flow growth

  • Ownership and control of the most relevant land locations limits competition for other landlords and is a significant competitive advantage

  • A five-year development track record of delivering approximately 800,000 square feet annually that have been 90% leased, on average

  • An attractive and secure quarterly dividend of $0.275/share represents a 3.8% yield and a 1.4 percentage point premium to the 2.4% yield from 10-year US Treasuries

  • An investment grade-rated balance sheet supports future growth through development, and ensures dividend safety


LTC Properties Inc. (NYSE:LTC) is a California-based real estate investment trust that invests in seniors housing and health care properties, targeting the growing market of aging baby boomers. The company primarily invests in properties through sale-leaseback transactions, mortgage financing, and structured finance solutions. LTC’s experienced management team is dedicated to generating a diversified portfolio through a disciplined investment approach.

  • 219 investments across 30 states
  • Strong year-over-year revenue growth of approximately 19%
  • Annual dividend growth of approximately 77% since 2005
  • A conservative balance sheet with significant liquidity and minimal debt maturities


1-800-FLOWERS.COM, Inc. (FLWS:NASDAQ) has created a multibrand platform of gifting options for customers, integrating gourmet food and gift baskets and other products into its offerings, as well as continuing to grow its flagship consumer floral marketplace.

  • A gift industry leader with revenues of $1.17 billion in fiscal 2016
  • Three key business segments: Gourmet Food & Gift Baskets, Consumer Floral, and
    BloomNet Wire Service
  • Strong balance sheet; strong free cash flow
  • A multibrand website that enhances customer behavior metrics, including increased retention,
    frequency, and lifetime value
  • A proven ability to leverage the business platform to reduce operating expenses (opex)






Brixmor Property Group (BRX:NYSE) is an open-air retail landlord operating on a national platform, with properties in New York, Chicago, Houston, Los Angeles, and other key markets. By partnering with high-visibility and well-respected retailers such as Kroger, TJX Companies, and Publix, Brixmor seeks to maximize productivity by focusing on local customer demand, thereby increasing foot traffic for its tenants, building a solid foundation for success, and creating a compelling value proposition for investors. 

  • The second-largest open-air retail landlord in the United States
  • More than 500 properties in a geographically diversified portfolio
  • A self-funded reinvestment pipeline with yields of ~10% 
  • ~5,600 national, regional, and local tenants 


CVS Health Corporation (NYSE:CVS) is a pharmacy innovation company helping people, businesses, and communities manage health in more affordable, effective ways. The integrated CVS Health model increases access to quality care, delivers better health outcomes, and lowers overall healthcare costs.

  • Ranked #7 on the 2016 Fortune 500 list
  • Fourteen consecutive years of dividend increases
  • The largest pharmacy in the United States based on total prescription revenue
  • 2.3 billion adjusted prescriptions filled or managed annually


RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV:RP) is a regenerative medicine company developing cell therapies to treat conditions related to a deficit of healthy cells needed to heal and restore function.

Stem Cell Therapies With Major Catalysts Ahead, by George S. Mack

The single most important share-price driver in the small- or micro-cap biotech space is the presence of a near-term catalyst that could boost share price. The smaller a company’s market valuation, the greater the potential impact of market-moving data. 


Find more investment opportunities from the Featured Companies menu above.

View our Featured Company archive.